In a patient with acute pericarditis, 70‑lb unintentional weight loss, and elevated liver function tests (predominantly alkaline phosphatase), what additional diagnostic workup should be performed?

Workup for Acute Pericarditis with Severe Weight Loss and Elevated Alkaline Phosphatase

This patient requires urgent evaluation for malignancy (particularly lung cancer, breast cancer, or lymphoma with metastatic disease) and tuberculosis, as these are the most likely life-threatening etiologies given the constellation of acute pericarditis, severe constitutional symptoms (70-lb weight loss), and cholestatic liver injury.

Risk Stratification

This patient presents with multiple high-risk features that mandate aggressive workup. The 2015 ESC Guidelines identify specific features associated with poor prognosis and specific etiologies 1:

• Subacute onset with constitutional symptoms (70-lb unintentional weight loss is a major red flag)
• Elevated alkaline phosphatase suggests either biliary obstruction or infiltrative liver disease
• These features shift the differential away from benign idiopathic/viral pericarditis toward neoplastic or tuberculous etiologies

The ESC Guidelines explicitly state that neoplastic causes (especially lung cancer, breast cancer, and lymphoma) and tuberculosis carry intermediate to high risk (2-30%) for developing constrictive pericarditis and have worse overall prognosis 1.

Immediate Diagnostic Workup

1. Imaging Studies

Chest CT with IV contrast is the priority imaging study:

• Evaluate for primary lung malignancy or mediastinal lymphadenopathy
• Assess pericardial thickening and effusion characteristics
• Identify pulmonary tuberculosis or miliary disease

Abdominal imaging for elevated alkaline phosphatase 2:

• MRI abdomen with MRCP is the most appropriate initial study for cholestatic predominance with elevated ALP
• Alternatively, CT abdomen/pelvis with IV contrast can identify:
  • Hepatic metastases
  • Biliary obstruction from malignancy
  • Lymphadenopathy
  • Ascites

2. Laboratory Evaluation

Tuberculosis screening (critical given TB is the leading cause of pericarditis worldwide and carries 20-30% risk of constriction) 1:

• Interferon-gamma release assay (IGRA) or tuberculin skin test
• Sputum acid-fast bacilli smears and cultures (3 samples)
• Consider HIV testing (TB-HIV co-infection is common) 1

Malignancy workup:

• Complete blood count with differential (lymphoma, leukemia)
• Lactate dehydrogenase (LDH) - elevated in lymphoma
• Serum protein electrophoresis if multiple myeloma suspected
• Tumor markers: CEA, CA 19-9, AFP (though non-specific)

Liver function panel expansion:

• Gamma-glutamyl transpeptidase (GGT) to confirm hepatobiliary source of ALP 2
• Total and direct bilirubin
• Albumin and prothrombin time (assess synthetic function)
• Hepatitis B surface antigen, hepatitis B core antibody, hepatitis C antibody 3

Inflammatory markers:

• C-reactive protein (CRP) - guides pericarditis treatment response 1
• Erythrocyte sedimentation rate (ESR)

Autoimmune screening (lower priority given weight loss, but consider):

• Antinuclear antibody (ANA)
• Rheumatoid factor
• Anti-dsDNA if lupus suspected 1

3. Invasive Procedures

Pericardiocentesis with fluid analysis - strongly consider if moderate-to-large effusion present:

• Cell count and differential
• Cytology (malignant cells)
• Adenosine deaminase (ADA) level >40 U/L suggests tuberculous pericarditis
• Acid-fast bacilli smear and mycobacterial culture
• Bacterial culture and Gram stain
• Pericardial fluid protein, glucose, LDH

Pericardial biopsy may be necessary if:

• Pericardiocentesis is non-diagnostic
• Strong suspicion for malignancy or tuberculosis persists
• Consider surgical window or pericardioscopy

Critical Pitfalls to Avoid

1. Do not assume idiopathic/viral pericarditis in the presence of severe weight loss - this represents a high-risk presentation requiring specific etiologic diagnosis 4

2. Do not delay tuberculosis evaluation - TB pericarditis has 20-30% risk of constriction and requires immediate antitubercular therapy 1

3. Do not attribute elevated ALP solely to cardiac disease - while congestive hepatopathy can elevate ALP 5, 70-lb weight loss makes infiltrative malignancy or biliary obstruction far more likely

4. Do not start empiric corticosteroids before excluding infectious causes (TB, purulent pericarditis) - steroids are contraindicated until infection is ruled out 1

Algorithmic Approach

Step 1: Obtain chest CT with contrast + abdominal imaging (MRI with MRCP or CT with contrast)

Step 2: Send TB screening (IGRA/TST) + sputum AFB + HIV test

Step 3: If pericardial effusion present, perform pericardiocentesis with comprehensive fluid analysis including ADA and cytology

Step 4: Based on imaging results:

• If mass lesion identified → biopsy for tissue diagnosis
• If lymphadenopathy → consider PET-CT for staging
• If biliary obstruction → ERCP with brushings

Step 5: If all non-invasive testing non-diagnostic and suspicion remains high → surgical pericardial biopsy

The combination of acute pericarditis with severe constitutional symptoms and cholestatic liver injury represents a medical emergency requiring rapid, systematic evaluation for treatable but potentially fatal conditions 1, 6.